Effects of Sleep Restriction on BAT Activation in Humans (BAT)
Primary Purpose
Sleep Deprivation, Obesity
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Partial Sleep Restriction
Total Sleep Deprivation
Habitual Sleep
Sponsored by
About this trial
This is an interventional prevention trial for Sleep Deprivation focused on measuring sleep restriction, obesity, brown adipose tissue
Eligibility Criteria
Inclusion Criteria:
Normal scores on:
- Pittsburgh Quality of Sleep Questionnaire
- Epworth Sleepiness Scale
- Berlin Questionnaire
- Sleep Disorders Inventory Questionnaire
- Beck Depression Inventory
- Composite Scale of Morningness/Eveningness
- Three Factor Eating Questionnaire
- Sleep 7-9 hours in bed/night with no daytime nap
- Age 20-49 years, premenopausal women
- All racial/ethnic groups
- Body mass index 25-29.9 kg/m2
Exclusion Criteria:
- Smokers (any cigarettes or ex-smoker <3 years)
- Neurological, medical or psychiatric disorder, diabetics
- Eating and/or sleep disorders
- Contraindications for MRI scanning
- Travel across time zones within 4 weeks
- History of drug and alcohol abuse
- Shift worker (or rotating shift worker)
- Caffeine intake >300 mg/d
- Pregnancy or within 1 y post-partum
- Heavy equipment operators Commercial long-distance drivers
Sites / Locations
- New York Nutrition Obesity Research Center
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
PSR-TSD
TSD-PSR
Arm Description
Partial sleep restriction (PSR) followed by total sleep deprivation (TSD). Experimental procedures will begin with a 3-day period of habitual sleep (HS).
Total sleep deprivation (TSD) followed by partial sleep restriction (PSR). Experimental procedures will begin with a 3-day period of habitual sleep (HS).
Outcomes
Primary Outcome Measures
Change from baseline Brown adipose tissue (BAT) in 6 weeks
Assessed by positron emission tomography and magnetic resonance combined scanner (PET/MR) using 18F-fluorodeoxyglucose (18FDG-PET). Fat fraction (FF) measurement under cold stimulation is to be measured.
Secondary Outcome Measures
Difference in weight from baseline at 6 weeks
Assessed by body composition and anthropometric measurements.
Difference in Glucose level from baseline at 6 weeks
Assessed by fasting blood samples
Full Information
NCT ID
NCT02770118
First Posted
February 10, 2016
Last Updated
July 17, 2017
Sponsor
Columbia University
Collaborators
New York University
1. Study Identification
Unique Protocol Identification Number
NCT02770118
Brief Title
Effects of Sleep Restriction on BAT Activation in Humans
Acronym
BAT
Official Title
Effects of Sleep Restriction on BAT Activation in Humans
Study Type
Interventional
2. Study Status
Record Verification Date
July 2017
Overall Recruitment Status
Completed
Study Start Date
January 2016 (Actual)
Primary Completion Date
June 2017 (Actual)
Study Completion Date
July 2017 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Columbia University
Collaborators
New York University
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The goal of this proposed research is to test the hypothesis that long-term mild sleep restriction (SR), as occurs frequently in adults and adolescents, leads to a positive energy balance and weight gain.
Aim 1. To determine the effects of SR, relative to habitual sleep (HS), on food choice and energy intake (EI) in adults at risk of obesity.
Hypothesis 1a. EI, assessed by multiple weekly 24-hour recalls, will be greater during a period of SR relative to HS. This will be mostly due to increased fat and carbohydrate intakes.
Hypothesis 1b. Neuronal responses to food stimuli, assessed by functional MRI (fMRI) after 6 weeks of SR or HS, will indicate increased activity in networks associated with reward and food valuation (insula, orbitofrontal cortex) during a period of SR relative to HS. These responses will be correlated with intakes of high carbohydrate and high fat foods (hypothesis 1a) and neuropeptide Y (NPY). Moreover, activation of the default mode network (DMN) will be suppressed to a lesser extent after SR compared to HS.
Aim 2. To determine the effects of SR, relative to HS, on energy expenditure (EE) via independent and complementary approaches.
Hypothesis 2a. EE, assessed by doubly-labeled water (DLW), and physical activity level, monitored daily by actigraphy, will be lower during SR relative to HS.
Hypothesis 2b. Brown adipose tissue (BAT), assessed by positron emission tomography and magnetic resonance combined scanner (PET/MR) using 18F-fluorodeoxyglucose (18FDG-PET) and fat fraction (FF) measurement under cold stimulation, will be greater after SR relative to HS. This would suggest higher adaptive thermogenesis after SR compared to HS. BAT activation will also be correlated with NPY.
Aim 3. To determine whether SR alters body weight and adiposity relative to HS.
Hypothesis 3a. SR will lead to weight gain and increased total adiposity, as assessed using magnetic resonance imaging (MRI), relative to HS.
Hypothesis 3b. Increased adiposity after SR will be correlated to an adverse cardio-metabolic risk profile (increased glucose, insulin, triglycerides, leptin, reduced high-density lipoprotein cholesterol and adiponectin) and neuronal responses to food stimuli (Hypothesis 1b), and EE (Hypothesis 2a & 2b). Failure to stimulate BAT with SR will be associated with greater gain in adiposity.
Detailed Description
There is an association between short sleep duration (SSD) and obesity. Moreover, short sleepers (<7 hours sleep/night) gain more weight over time than normal sleepers (7-8 hours sleep/night). These relationships are increasingly supported by clinical data showing that restricting sleep duration in healthy, normal weight adults, increases energy intake (EI).
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sleep Deprivation, Obesity
Keywords
sleep restriction, obesity, brown adipose tissue
7. Study Design
Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
4 (Actual)
8. Arms, Groups, and Interventions
Arm Title
PSR-TSD
Arm Type
Experimental
Arm Description
Partial sleep restriction (PSR) followed by total sleep deprivation (TSD). Experimental procedures will begin with a 3-day period of habitual sleep (HS).
Arm Title
TSD-PSR
Arm Type
Experimental
Arm Description
Total sleep deprivation (TSD) followed by partial sleep restriction (PSR). Experimental procedures will begin with a 3-day period of habitual sleep (HS).
Intervention Type
Behavioral
Intervention Name(s)
Partial Sleep Restriction
Other Intervention Name(s)
PSR
Intervention Description
4 hour time in bed (TIB), participants will go to bed 4 hours later than during the HS condition. Wake-up times will be the same. During the in-lab portion of the PSR, meals, fulfilling weight-maintenance energy requirements, will be supplied by the research staff as BOOST shakes.
Intervention Type
Behavioral
Intervention Name(s)
Total Sleep Deprivation
Other Intervention Name(s)
TSD
Intervention Description
0 hour time in bed (TIB), participants will remain awake throughout the night. Meals will be provided as BOOST shakes at the same meal.
Intervention Type
Behavioral
Intervention Name(s)
Habitual Sleep
Other Intervention Name(s)
HS
Intervention Description
8 hours time in bed (TIB), for 3 nights, with fixed bed and wake times, while at home. During the 3-d HS phase, participants will be provided will BOOST meal replacement shakes in amounts required to achieve weight maintenance.
Primary Outcome Measure Information:
Title
Change from baseline Brown adipose tissue (BAT) in 6 weeks
Description
Assessed by positron emission tomography and magnetic resonance combined scanner (PET/MR) using 18F-fluorodeoxyglucose (18FDG-PET). Fat fraction (FF) measurement under cold stimulation is to be measured.
Time Frame
6 weeks
Secondary Outcome Measure Information:
Title
Difference in weight from baseline at 6 weeks
Description
Assessed by body composition and anthropometric measurements.
Time Frame
6 weeks
Title
Difference in Glucose level from baseline at 6 weeks
Description
Assessed by fasting blood samples
Time Frame
6 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
49 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Normal scores on:
Pittsburgh Quality of Sleep Questionnaire
Epworth Sleepiness Scale
Berlin Questionnaire
Sleep Disorders Inventory Questionnaire
Beck Depression Inventory
Composite Scale of Morningness/Eveningness
Three Factor Eating Questionnaire
Sleep 7-9 hours in bed/night with no daytime nap
Age 20-49 years, premenopausal women
All racial/ethnic groups
Body mass index 25-29.9 kg/m2
Exclusion Criteria:
Smokers (any cigarettes or ex-smoker <3 years)
Neurological, medical or psychiatric disorder, diabetics
Eating and/or sleep disorders
Contraindications for MRI scanning
Travel across time zones within 4 weeks
History of drug and alcohol abuse
Shift worker (or rotating shift worker)
Caffeine intake >300 mg/d
Pregnancy or within 1 y post-partum
Heavy equipment operators Commercial long-distance drivers
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marie-Pierre St-Onge, Ph.D
Organizational Affiliation
Assistant Professor of Nutritional Medicine
Official's Role
Principal Investigator
Facility Information:
Facility Name
New York Nutrition Obesity Research Center
City
New York
State/Province
New York
ZIP/Postal Code
10032
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Effects of Sleep Restriction on BAT Activation in Humans
We'll reach out to this number within 24 hrs